1921
Volume 90, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

There are no published data on the economic burden for specific West Nile virus (WNV) clinical syndromes (i.e., fever, meningitis, encephalitis, and acute flaccid paralysis [AFP]). We estimated initial hospital and lost-productivity costs from 80 patients hospitalized with WNV disease in Colorado during 2003; 38 of these patients were followed for 5 years to determine long-term medical and lost-productivity costs. Initial costs were highest for patients with AFP (median $25,117; range $5,385–$283,381) and encephalitis (median $20,105; range $3,965–$324,167). Long-term costs were highest for patients with AFP (median $22,628; range $624–$439,945) and meningitis (median $10,556; range $0–$260,748). Extrapolating from this small cohort to national surveillance data, we estimated the total cumulative costs of reported WNV hospitalized cases from 1999 through 2012 to be $778 million (95% confidence interval $673 million–$1.01 billion). These estimates can be used in assessing the cost-effectiveness of interventions to prevent WNV disease.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.13-0206
2014-03-05
2017-12-12
Loading full text...

Full text loading...

/deliver/fulltext/14761645/90/3/402.html?itemId=/content/journals/10.4269/ajtmh.13-0206&mimeType=html&fmt=ahah

References

  1. Lindsey NP, Staples JE, Lehman JA, Fischer M, , 2010. Surveillance for human West Nile virus disease - United States, 1999–2008. MMWR Surveill Summ 59: 117.
  2. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, Huang A, Rosenberg A, Greenberg A, Sherman M, Wong S, Layton M, , 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 18071814.[Crossref]
  3. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ, , 2002. West Nile virus. Lancet Infect Dis 2: 519529.[Crossref]
  4. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, Gerber SI, , 2004. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med 141: 360365.[Crossref]
  5. Sejvar JJ, Marfin AA, , 2006. Manifestations of West Nile neuroinvasive disease. Rev Med Virol 16: 209224.[Crossref]
  6. Klee AL, Maidin B, Edwin B, Poshni I, Mostashari F, Fine A, Layton M, Nash D, , 2004. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 10: 14051411.[Crossref]
  7. Cook RL, Xu X, Yablonsky EJ, Sakata N, Tripp JH, Hess R, Piazza P, Rinaldo CR, , 2010. Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. Am J Trop Med Hyg 83: 11331136.[Crossref]
  8. Carson PJ, Konewko P, Wold KS, Mariani P, Goli S, Bergloff P, Crosby RD, , 2006. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 43: 723730.[Crossref]
  9. Sejvar JJ, , 2007. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 44: 16171624.[Crossref]
  10. Centers for Disease Control and Prevention, 2010. West Nile virus activity - United States, 2009. MMWR Morb Mortal Wkly Rep 59: 769772.
  11. Centers for Disease Control and Prevention, 2013. West Nile virus disease cases and presumptive viremic blood donors reported to ArboNET, United States, 2011. Available at: http://www.cdc.gov/westnile/statsMaps/finalMapsData/data/2011WNVHumanInfectionsbyState.pdf. Accessed January 9, 2014.
  12. Centers for Disease Control and Prevention, 2012. West Nile virus disease and other arboviral diseases - United States, 2011. MMWR Morb Mortal Wkly Rep 61: 510514.
  13. Barber LM, Schleier JJ, Peterson RK, , 2010. Economic cost analysis of West Nile virus outbreak, Sacramento County, California, USA, 2005. Emerg Infect Dis 16: 480486.[Crossref]
  14. Zohrabian A, Meltzer MI, Ratard R, Billah K, Molinari NA, Roy K, Scott RD, Petersen LR, , 2004. West Nile virus economic impact, Louisiana, 2002. Emerg Infect Dis 10: 17361744.[Crossref]
  15. Grosse SD, Krueger KV, Mvundura M, , 2009. Economic productivity by age and sex: 2007 estimates for the United States. Med Care 47: s94s103.[Crossref]
  16. Bode AV, Sejvar JJ, Pape WJ, Campbell GL, Marfin AA, , 2006. West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 42: 12341240.[Crossref]
  17. Sejvar JJ, Curns AT, Welburg L, Jones JF, Lundgren LM, Capuron L, Pape J, Reeves WC, Campbel GL, , 2008. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol 2: 477499.[Crossref]
  18. Bretz F, Hothorn T, Westfall P, , 2010. Multiple Comparisons Using R. Boca Raton, FL: Chapman & Hall/CRC.[Crossref]
  19. Davis LE, DeBiasi R, Goade DE, Haaland KY, Harrington JA, Harnar JB, Pergam SA, King MK, DeMasters BK, Tyler KL, , 2006. West Nile virus neuroinvasive disease. Ann Neurol 60: 286300.[Crossref]
  20. Frenzen PD, , 2008. Economic cost of Guillain-Barré syndrome in the United States. Neurol 71: 2127.[Crossref]
  21. Khetsuriani N, Holman RC, Anderson LJ, , 2002. Burden of encephalitis-associated hospitalizations in the United States, 1988–1997. Clin Infect Dis 35: 175182.[Crossref]
  22. Holmquist L, Russo CA, Elixhauser A, , 2008. Meningitis-related hospitalizations in the United States, 2006: Statistical Brief #57. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Health Care Policy and Research. Available at: http://www.ncbi.nlm.nih.gov/books/NBK56046/21. Accessed August 21, 2013.
  23. Weber IB, Lindsey NP, Bunko-Patterson AM, Briggs G, Wadleigh TJ, Sylvester TL, Levy C, Komatsu KK, Lehman JA, Fischer M, Staples JE, , 2012. Completeness of West Nile virus testing in patients with meningitis and encephalitis during an outbreak in Arizona, USA. Epidemiol Infect 140: 16321636.[Crossref]
  24. Henry J, Kaiser Family Foundation; , 2013. Health Care Expenditures per Capita by Service by State of Residence. Available at: http://kff.org/other/state-indicator/health-spending-per-capita-by-service/. Accessed July 31, 2013.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.13-0206
Loading
/content/journals/10.4269/ajtmh.13-0206
Loading

Data & Media loading...

  • Received : 19 Apr 2013
  • Accepted : 27 Nov 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error